Literature DB >> 8605085

Dietary and metabolite effects on trivalent chromium retention and distribution in rats.

R A Anderson1, M M Polansky.   

Abstract

The purpose of this study was to determine if diet or various metabolites alter chromium (Cr) uptake and distribution in rats. Radioactively labeled Cr was detected within 15 min of oral administration to rats, and the total amount retained remained relatively constant from 1 to 24 h. Dietary Cr intake did not alter Cr retention or distribution. The majority of the Cr was retained in the carcass. However, when the amount of labeled Cr was expressed per gram of tissue, the highest amounts of Cr were found in the kidneys, spleen, and pancreas. Pharmacological doses of insulin, epinephrine, glucagon, and dibutyryladenosine-3'-5'cyclic monophosphate, prostaglandins A1, A2, B1, B2, E1, E2, F1 alpha, and F2 alpha did not significantly influence Cr retention. Glucose, sucrose, nicotinic acid, glutathione, and other metabolites administered orally in conjunction with labeled Cr also did not significantly alter Cr retention. These data indicate that most nutrients and metabolites do not alter Cr retention and distribution. The regulation of Cr homeostasis appears to be at the level of excretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8605085     DOI: 10.1007/BF02789412

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  19 in total

1.  CHROMIUM (3) BINDING TO SERUM PROTEINS, SPECIFICALLY SIDEROPHILIN.

Authors:  L L HOPKINS; K SCHWARZ
Journal:  Biochim Biophys Acta       Date:  1964-09-04

2.  Metabolism of Cr51 by animals as influenced by chemical state.

Authors:  W J VISEK; I B WHITNEY; U S KUHN; C L COMAR
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

3.  Chromium deficiency after long-term total parenteral nutrition.

Authors:  R O Brown; S Forloines-Lynn; R E Cross; W D Heizer
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

4.  Effect of chelating agents on chromium absorption in rats.

Authors:  N S Chen; A Tsai; I A Dyer
Journal:  J Nutr       Date:  1973-08       Impact factor: 4.798

5.  Radiochromium distribution in thyroid and parathyroid deficiency.

Authors:  M L Lifschitz; S Wallach; R A Peabody; R L Verch; R Agrawal
Journal:  Am J Clin Nutr       Date:  1980-01       Impact factor: 7.045

6.  Chromium deficiency during total parenteral nutrition.

Authors:  H Freund; S Atamian; J E Fischer
Journal:  JAMA       Date:  1979-02-02       Impact factor: 56.272

7.  Essentiality of chromium in humans.

Authors:  R A Anderson
Journal:  Sci Total Environ       Date:  1989-10-01       Impact factor: 7.963

8.  Breast milk chromium and its association with chromium intake, chromium excretion, and serum chromium.

Authors:  R A Anderson; N A Bryden; K Y Patterson; C Veillon; M B Andon; P B Moser-Veillon
Journal:  Am J Clin Nutr       Date:  1993-04       Impact factor: 7.045

9.  Radiochromium distribution in aged rats.

Authors:  S Wallach; R L Verch
Journal:  J Am Coll Nutr       Date:  1986       Impact factor: 3.169

10.  Tissue chromium exchange in the rat.

Authors:  R Jain; R L Verch; S Wallach; R A Peabody
Journal:  Am J Clin Nutr       Date:  1981-10       Impact factor: 7.045

View more
  3 in total

1.  Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis.

Authors:  Geng-Ruei Chang; Yi-Shin Chiu; Ying-Ying Wu; Yu-Chi Lin; Po-Hsun Hou; Frank Chiahung Mao
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

2.  Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.

Authors:  Buffie J Clodfelder; Bryan M Gullick; Henry C Lukaski; Yasmin Neggers; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2004-12-30       Impact factor: 3.358

Review 3.  The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent.

Authors:  John B Vincent
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.